Angiodynamics reports fiscal 2021 third quarter financial results and updates guidance

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the third quarter of fiscal year 2021, which ended february 28, 2021. “i am pleased with our strong third quarter performance, driven by continued strength in our angiovac and auryon platforms. our revenue grew 2% year over year despite continued covid-19 headw
ANGO Ratings Summary
ANGO Quant Ranking